Acquired Hemolytic Anemia — VA Disability Rating (DC 7723)
Diagnostic Code 7723 · 38 CFR §4.117
What Is It?
Acquired hemolytic anemia is a condition where the body destroys its own red blood cells faster than the bone marrow can replace them. Unlike inherited forms of hemolytic anemia (like sickle cell disease), acquired hemolytic anemia develops after birth due to external triggers. The immune system may mistakenly attack red blood cells (autoimmune hemolytic anemia), or the destruction may be triggered by infections, medications, toxins, or mechanical damage to blood cells. Symptoms include fatigue, weakness, jaundice (yellowing of the skin and eyes), dark urine, rapid heartbeat, shortness of breath, and an enlarged spleen. For veterans, acquired hemolytic anemia can result from autoimmune reactions triggered by infections contracted during deployment, reactions to medications prescribed during service, toxic chemical or environmental exposures, or as a complication of other service-connected conditions like lupus or lymphoma. The condition can be episodic with flare-ups and remissions, or chronic and persistent.
Rating Criteria
| Rating | Criteria |
|---|---|
| 100% | Refractory hemolytic anemia requiring frequent transfusions, plasmapheresis, or splenectomy consideration despite maximum medical therapy. Life-threatening hemolytic crises and inability to sustain any meaningful daily activity. |
| 70% | Severe hemolytic anemia with frequent hemolytic episodes despite treatment, requiring high-dose immunosuppression or multiple drug regimens. Persistent moderate-to-severe anemia with substantial fatigue, recurrent jaundice, and limited ability to maintain employment. |
| 30% | Moderate hemolytic anemia requiring ongoing immunosuppressive medication (such as corticosteroids), with periodic flare-ups causing noticeable jaundice, increased fatigue, and need for dose adjustments or additional treatment. |
| 10% | Mild chronic hemolysis with slightly reduced hemoglobin, manageable with monitoring or low-dose medication. Occasional fatigue that limits stamina but does not prevent daily activities. |
| 0% | History of acquired hemolytic anemia that has fully resolved with stable hemoglobin and no ongoing hemolysis markers. No current treatment needed. |
Evidence Needed
Lab work demonstrating hemolysis is the diagnostic cornerstone: elevated reticulocyte count (bone marrow trying to compensate), elevated bilirubin and lactate dehydrogenase (from red blood cell destruction), low haptoglobin, and a positive direct antiglobulin test (Coombs test) for autoimmune types. Serial CBC results showing the pattern of anemia are important. Treatment records documenting corticosteroids, immunosuppressive drugs, transfusions, or splenectomy demonstrate severity. If triggered by a medication, infection, or toxic exposure during service, medical records documenting the timeline and a nexus opinion connecting the trigger to service are needed.
C&P Exam Tips
Describe the pattern of your condition — is it chronic and constant, or does it flare up and remit? If episodic, describe the frequency, severity, and duration of hemolytic episodes. Describe visible symptoms like jaundice and dark urine when they occur. Explain your medication regimen and its side effects, especially if you are on long-term steroids (weight gain, bone thinning, diabetes risk, mood changes). If you have had your spleen removed as treatment, that should be rated separately. Explain how unpredictable flare-ups affect your ability to maintain consistent employment.
How to File
File on VA Form 21-526EZ with DC 7723. Submit hemolysis lab work (reticulocytes, bilirubin, haptoglobin, Coombs test), CBC results, and treatment records. If triggered by an in-service medication, infection, or exposure, document that timeline and include a nexus opinion. If splenectomy was performed as treatment, file separately under DC 7706.
Common Mistakes
Not submitting the specific hemolysis lab markers (reticulocytes, bilirubin, haptoglobin) in addition to the basic CBC — these are what distinguish hemolytic anemia from other types. Not documenting the trigger for the hemolysis weakens the nexus to service. If on long-term corticosteroids, not filing for steroid side effects (weight gain, osteoporosis, diabetes) as secondary conditions misses additional compensation. Not filing separately for splenectomy if the spleen was removed.
Frequently Asked Questions
What triggers acquired hemolytic anemia in veterans?
Common triggers include autoimmune reactions (sometimes triggered by infections or stress), medications, toxic exposures, and complications of other conditions like lupus. The condition is called acquired because it develops from an external trigger rather than being inherited.
If I need a splenectomy for hemolytic anemia, is that rated separately?
Yes. Splenectomy is rated at a fixed 20 percent under DC 7706, separate from the hemolytic anemia rating under DC 7723. Both ratings contribute to your combined disability percentage.